Furosemide

HISA's Furosemide RFP Deadline Extended to Nov. 22

The submission deadline for HISA's furosemide request for proposals (RFP) has been extended to Nov. 22 from the original date of Oct. 15. The proposals should address furosemide's effects on horse health and racing performance. Click here for more information, including contact information, and here for the application.

[ Read More ]
HISA Requests Furosemide Proposals

The Horseracing Integrity and Safety Authority has released a request for proposals for research into whether furosemide is a performance-enhancing drug in Thoroughbred racehorses. The research is required as part of HISA's Congressional mandate and its conclusions will be used to guide HISA's Furosemide Advisory Committee in its recommendations to the HISA Board on next steps regarding the regulation of furosemide. Responses to the RFP are due by Oct. 15 at 11:59 p.m. ET. Questions about the RFP and the process for submitting a response may be sent to Dr....

[ Read More ]
HISA To Fund Three Scientific Studies On The Use of Furosemide

Following a recommendation from its Furosemide Advisory Committee (FAC), the Horseracing Integrity and Safety Authority's Board of Directors approved $773,500 in grant funding for three scientific studies on the use of furosemide (also known as "Lasix") to be conducted over the next two years by the Nationwide Children's Hospital, the University of Florida College of Veterinary Medicine and Washington State University, HISA said in a Wednesday release. The studies will examine the 48-hour period before the start of a Covered Horserace, including the effects of furosemide on equine health and...

[ Read More ]
HISA Releases Request For Furosemide Research Proposals

HISA released a request for proposals concerning research over the administration of furosemide to Thoroughbred racehorses during the 48-hour period before the start of a race, the organization said in a release late Tuesday. This research is required as part of HISA's Congressional mandate. The conclusions will be used to guide HISA's Furosemide Advisory Committee in its recommendations to their Board on the next course of action regarding the administration of the drug. Responses are due by Nov. 15 at 11:59 pm (ET). Questions pertaining to the process for submitting...

[ Read More ]
Research Proposals on Lasix will be Accepted by HISA Sept. 1

The Horseracing Integrity and Safety Authority called for potential researchers to prepare research proposals on the administration of furosemide, still commonly called Lasix in racing, to Thoroughbred racehorses during the 48-hour period before the start of a race, the organization said in a release Thursday evening. The call for proposals is expected to be released Sept. 1. As the Authority was created by the Horseracing Integrity and Safety Act (HISA) of 2020, it is mandated by Congress to include at least one study on the use of furosemide. Included in...

[ Read More ]
HISA's Lasix Advisory Committee Set

Edited Press Release The Horseracing Integrity and Safety Authority (HISA) announced the members of an Advisory Committee which has been convened to oversee a three-year study on the use of furosemide (also known as "Lasix") on horses during the 48-hour period before the start of a Covered Horserace, including the effect on equine health and the integrity of competition. The establishment of this Advisory Committee for the study of furosemide administration and the requirements of the study are specifically mandated and set forth in the Horseracing Integrity and Safety Act....

[ Read More ]
Study: Horses On Lasix At Increased Risk of 'Sudden Death'

A new study published this week in the Journal of the American Veterinary Medical Association and funded by the Grayson Jockey Club Foundation, has found that horses racing on Lasix were 62% more likely to die within three days of racing than were horses running without the diuretic. Fatalities due to catastrophic musculoskeletal injury were not included in the study. The use of Lasix was one of 15 risk factors identified in the report. The study, relying on information from the Equine Injury Database, examined starts made by 284,387 Thoroughbreds...

[ Read More ]
Major Racing Organizations to Jointly Fund Study On Lasix in 2-Year-Olds

The Stronach Group, Breeders' Cup Ltd., Churchill Downs Inc., Keeneland, the Kentucky Horse Racing Commission, the Kentucky Thoroughbred Association and the New York Racing Association, Inc. have agreed to jointly fund North America's largest study on the effects of furosemide and on the prevalence and severity of Exercise-Induced Pulmonary Hemorrhage (EIPH) in 2-year-old racehorses. The study, formally titled Furosemide: Its Effects on the Prevalence and Severity of Exercise-Induced Pulmonary Hemorrhage (EIPH) and the Immune System's Normal Response to Exercise in Two-Year-Old Racehorses, began this month and is being led by...

[ Read More ]
Letter to the Editor: Chester Thomas

The past two years Allied Racing LLC has achieved our dreams of competing at horse racing's top level, headed by my first multiple graded-stakes winner and Kentucky Derby runner By My Standards and multiple graded winner Mr. Money. I'd hoped it was just the start of being in the top ranks of the sport we love dearly. But even as my wife and I ride this incredible wave, we plan to significantly downsize our stable. Why? Because of the movement to phase out the medication Lasix, a diuretic also used...

[ Read More ]
X

Never miss another story from the TDN

Click Here to sign up for a free subscription.